Veradigm, Surescripts Partner to Reduce Time-to-Fill for Specialty Medication Prescriptions
12 May 2020 - 10:01PM
Business Wire
Agreement facilitating the accelerated
fulfillment for hundreds more specialty medications across one of
healthcare’s largest provider networks
Allscripts (NASDAQ: MDRX) business unit Veradigm™, a leading
provider of data and technology solutions, today announced the
signing of an agreement with Surescripts to enhance its Veradigm
AccelRx™ specialty medication fulfillment solution with Surescripts
Specialty Patient Enrollment. The agreement will enable AccelRx to
support healthcare providers in more quickly fulfilling
prescriptions for hundreds more types of specialty medications by
incorporating Surescripts’ expansive health information network,
further streamlining healthcare providers’ management of specialty
medication within their electronic health record workflow.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200512005301/en/
Representing less than 3% of all prescriptions written in the
U.S. in 2020, specialty medications are expected to account for up
to 50% of the total drug spend.1 To receive their specialty
medication, a patient’s prescription must pass through a broad
cross-section of healthcare stakeholders, from biopharma companies
and payers, to specialty pharmacies and specialty medication hubs.
Each of these entities may have their own, standalone online portal
for facilitating fulfilment for a single drug or manufacturer. With
so many manufacturers and payers directly involved in the delivery
of specialty medications, it can be easy for providers and even
specialty medication hubs to be overwhelmed.
The result is often that instead of taking days to receive their
specialty medication, it takes weeks or even months. Despite this
rapid growth, recent data from Veradigm has shown that specialty
drugs are 50% less likely to be electronically prescribed.2
Combining one of healthcare’s largest prescriber bases with
broad industry partnerships built over decades of e-prescribing and
prior authorization leadership, Veradigm AccelRx delivers a unique
software platform designed to streamline specialty medication
fulfillment.
“Veradigm is excited to join with Surescripts in strengthening
the ability of Allscripts’ network of healthcare providers to
reduce or eliminate the many phone calls and faxes associated with
enrolling patients for specialty medication prescriptions,” says
Tom Langan, Veradigm CEO. “In our unique position at the nexus of
point-of-care patient solutions and clinical data insight, our many
biopharma and payer partners are looking to us for support in
streamlining this process. With this agreement, Veradigm AccelRx
will be enabled to deliver a solution for hundreds of specialty
medications and help us rapidly progress toward our goal of
covering every specialty medication for every therapeutic
area.”
By enabling providers to enroll patients into specialty programs
in the EHR and coordinating information sent to the pharmacy, while
the patient is still in their office, Veradigm AccelRx, in
collaboration with partners like Surescripts, delivers the tools
providers need to overcome the existing gaps and speed up the
specialty medication fulfillment process.
“When we replace manual work with an accurate, electronic
workflow, patients get essential therapies sooner and providers
have more time to do what matters most, help patients,” said Mike
Pritts, Surescripts Chief Product Officer. “Together with Veradigm,
we can help drive meaningful change for all providers using AccelRx
to accelerate and simplify specialty medication enrollment to the
pharmacy and specialty medication hub.”
Learn more about the Veradigm AccelRx solution here.
1. Pharmaceutical Executive. 2015 Pharm Science Strategic
Outlook. 2015.
2. Data on file. 2019.
About Veradigm™
Veradigm is an integrated data systems and services company that
combines data-driven clinical insights with actionable tools to
help healthcare stakeholders improve the quality, efficiency, and
value of healthcare delivery — including biopharma, health plans,
healthcare providers, health technology partners, and most
importantly, the patients they serve. We are dedicated to
simplifying the complicated healthcare system with next-generation
healthcare solutions. This is how we are transforming health,
insightfully. To learn more, visit www.veradigmhealth.com.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial and
operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers and consumers to make better
decisions, delivering better care for healthier populations. To
learn more, visit www.allscripts.com, Twitter,
YouTube and It Takes A Community: The Allscripts
Blog.
© 2020 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are
trademarks of Allscripts Healthcare, LLC and/or its affiliates. All
other products are trademarks of their respective holders, all
rights reserved. Reference to these products is not intended to
imply affiliation with or sponsorship of Allscripts Healthcare, LLC
and/or its affiliates.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200512005301/en/
Investors: Stephen Shulstein
312-386-6735 Stephen.Shulstein@allscripts.com
Media: Concetta Rasiarmos
312-447-2466 concetta.rasiarmos@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2024 to May 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From May 2023 to May 2024